Caseware UK (AP4) 2023.0.135 2023.0.135 2024-03-312024-03-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.true5No description of principal activity2023-03-01falsetruefalse 14696146 2023-02-28 14696146 2023-03-01 2024-03-31 14696146 2022-03-01 2023-02-28 14696146 2024-03-31 14696146 1 2023-03-01 2024-03-31 14696146 d:Director2 2023-03-01 2024-03-31 14696146 c:OfficeEquipment 2023-03-01 2024-03-31 14696146 c:OfficeEquipment 2024-03-31 14696146 c:OfficeEquipment c:OwnedOrFreeholdAssets 2023-03-01 2024-03-31 14696146 c:CurrentFinancialInstruments 2024-03-31 14696146 c:CurrentFinancialInstruments c:WithinOneYear 2024-03-31 14696146 c:ShareCapital 2024-03-31 14696146 c:SharePremium 2024-03-31 14696146 c:RetainedEarningsAccumulatedLosses 2024-03-31 14696146 d:OrdinaryShareClass1 2023-03-01 2024-03-31 14696146 d:OrdinaryShareClass1 2024-03-31 14696146 d:FRS102 2023-03-01 2024-03-31 14696146 d:AuditExempt-NoAccountantsReport 2023-03-01 2024-03-31 14696146 d:FullAccounts 2023-03-01 2024-03-31 14696146 d:PrivateLimitedCompanyLtd 2023-03-01 2024-03-31 14696146 e:PoundSterling 2023-03-01 2024-03-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 14696146









BIOME9 LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE PERIOD ENDED 31 MARCH 2024

 
BIOME9 LIMITED
REGISTERED NUMBER: 14696146

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2024

2024
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
5,502

  
5,502

Current assets
  

Stocks
 5 
106,472

Debtors: amounts falling due within one year
 6 
36,464

Cash at bank and in hand
  
259,617

  
402,553

Creditors: amounts falling due within one year
 7 
(526,061)

Net current (liabilities)/assets
  
 
 
(123,508)

Total assets less current liabilities
  
(118,006)

  

Net (liabilities)/assets
  
(118,006)


Capital and reserves
  

Called up share capital 
 8 
1

Share premium account
  
550,000

Profit and loss account
  
(668,007)

  
(118,006)


The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 21 November 2024.

A H R Nathan
Page 1

 
BIOME9 LIMITED
REGISTERED NUMBER: 14696146
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2024

Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
BIOME9 LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2024

1.


General information

Biome9 Limited is a private company limited by shares and registered in England and Wales. The address of the registered office is 124 Finchley Road, London, England, NW3 5JS and the principal place of business is 14a Anyards Road, Cobham, Surrey, England, KT11 2JZ.  

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Going concern

These financial statements are prepared on the basis that the company will continue to be a going goncern for the foreseeable future. Note 10 provides details of further equity investment secured after the end of the current financial period. 

 
2.3

Foreign currency translation

The company's functional and presentational currency is GBP.

 
2.4

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

Page 3

 
BIOME9 LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.5

Pensions

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.
The contributions are recognised as an expense in the Statement of Comprehensive Income when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of Financial Position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, as follows.

Depreciation is provided on the following basis:

Office equipment
-
20%
per annum on the reducing balance

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.7

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a unit cost basis.
At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the Statement of Comprehensive Income.

 
2.8

Debtors

Short-term debtors are measured at transaction price, less any impairment. 

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Page 4

 
BIOME9 LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2024

2.Accounting policies (continued)

 
2.10

Creditors

Short-term creditors are measured at the transaction price.


3.


Employees

The average monthly number of employees, including directors, during the period was 5.


4.


Tangible fixed assets





Office equipment

£



Cost or valuation


Additions
6,877



At 31 March 2024

6,877



Depreciation


Charge for the period on owned assets
1,375



At 31 March 2024

1,375



Net book value



At 31 March 2024
5,502


5.


Stocks

2024
£

Goods for resale
106,472

106,472


Page 5

 
BIOME9 LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 MARCH 2024

6.


Debtors

2024
£


Other debtors
33,548

Prepayments
2,916

36,464



7.


Creditors: Amounts falling due within one year

2024
£

Trade creditors
70,095

Other taxation and social security
8,055

Other creditors
401,794

Accruals
46,117

526,061



8.


Share capital

2024
£
Allotted, called up and fully paid


1,111,100 ordinary shares shares of £0.000001 each
1


Allotted shares  
A ordinary 1,011,100
B ordinary   100,000
The classes have equal rights except that the B ordinary shares have no voting rights.


9.


Transactions with directors

During the period, consultancy fees of £75,000 were paid to a Limited Liability Partnership in which a director is a designated member.


10.


Post balance sheet events

The company successfully raised £170,000 of additional equity finance since the end of the financial period.

 
Page 6